Perbak Capital Partners LLP Illumina, Inc. Transaction History
Perbak Capital Partners LLP
- $187 Billion
- Q4 2024
A detailed history of Perbak Capital Partners LLP transactions in Illumina, Inc. stock. As of the latest transaction made, Perbak Capital Partners LLP holds 8,984 shares of ILMN stock, worth $873,244. This represents 0.64% of its overall portfolio holdings.
Number of Shares
8,984Holding current value
$873,244% of portfolio
0.64%Shares
1 transactions
Others Institutions Holding ILMN
# of Institutions
968Shares Held
151MCall Options Held
2.37MPut Options Held
1.41M-
Black Rock Inc. New York, NY18.1MShares$1.76 Billion0.04% of portfolio
-
Capital World Investors Los Angeles, CA18MShares$1.75 Billion0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.8MShares$1.54 Billion0.04% of portfolio
-
State Street Corp Boston, MA5.79MShares$563 Million0.03% of portfolio
-
Loomis Sayles & CO L P4.21MShares$409 Million0.71% of portfolio
About ILLUMINA, INC.
- Ticker ILMN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 157,300,000
- Market Cap $15.3B
- Description
- Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....